Skip to content
10-Q

Quarterly Report

Galileo Life Sciences, Inc.

0001471242-14-000287

← back to feed
Filed
Jul 31, 2014 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Jul 9, 2014 75.48M sh
Operating Cash Flow Q3 2014 · Mar 31, 2014 −$514.73K
Operating Cash Flow Q3 2014 · Mar 31, 2013 −$41.35K
Stockholders Equity Q3 2014 · Mar 31, 2014 −$583.09K
Stockholders Equity Q3 2014 · Jun 30, 2012 −$467.17K
Stockholders Equity restated Q3 2014 · Jun 30, 2011 −$103.55K
Stockholders Equity Q3 2014 · Jun 30, 2010 −$4.04K
Stockholders Equity Q3 2014 · Jun 30, 2009 −$1.77K
Stockholders Equity Q3 2014 · Jun 30, 2008 −$1.11K
Current Liabilities Q3 2014 · Mar 31, 2014 $583.09K
Current Liabilities Q3 2014 · Jun 30, 2013 $519.77K
Total Liabilities Q3 2014 · Mar 31, 2014 $583.09K
Total Liabilities Q3 2014 · Jun 30, 2013 $519.77K
Total Assets Q3 2014 · Mar 31, 2014 $0
Total Assets Q3 2014 · Jun 30, 2013 $0
Net Income Q3 2014 · Mar 31, 2014 −$648.36K
Net Income Q3 2014 · Jun 30, 2013 −$52.6K
Net Income Q3 2014 · Mar 31, 2013 −$3.21K
Net Income Q3 2014 · Mar 31, 2013 −$12.06K
Net Income Q3 2014 · Jun 30, 2012 −$363.62K
Net Income restated Q3 2014 · Jun 30, 2011 −$158.28K
Net Income Q3 2014 · Jun 30, 2010 −$8.78K
Net Income Q3 2014 · Jun 30, 2009 −$661
Net Income Q3 2014 · Jun 30, 2008 −$1.11K
Operating Income Q3 2014 · Mar 31, 2014 −$654.27K
Operating Income Q3 2014 · Mar 31, 2013 −$3.21K
Operating Income Q3 2014 · Mar 31, 2013 −$12.06K
Gross Profit Q3 2014 · Mar 31, 2014 $3.41K
Cost Of Revenue Q3 2014 · Mar 31, 2014 $6.1K
Revenue Q3 2014 · Mar 31, 2014 $9.51K